Search engine for other government resources

Moxifloxacin MedlinePlus Drug Information

Moxifloxacin may also be used to treat bronchitis or sinus infections but should not be used for these conditions if there are other treatment options ...
medlineplus.gov/druginfo/meds/a600002.html

Moxifloxacin Ophthalmic MedlinePlus Drug Information

Moxifloxacin ophthalmic solution is used to treat bacterial conjunctivitis (pink eye; infection of the membrane that covers the outside of the ...
medlineplus.gov/druginfo/meds/a605016.html

Moxifloxacin C21H24FN3O4 - PubChem

Moxifloxacin is a fourth generation fluoroquinolone with expanded activity against gram-positive bacteria as well as atypical pathogens. Moxifloxacin ...
pubchem.ncbi.nlm.nih.gov/compound/moxifloxacin

Moxifloxacin Injection MedlinePlus Drug Information

Moxifloxacin injection comes as a solution (liquid) to be given through a needle or catheter placed into a vein. It is usually infused (injected ...
medlineplus.gov/druginfo/meds/a608030.html

Moxifloxacin Hydrochloride - Patient NIH

Moxifloxacin hydrochloride is an antibacterial prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of ...
clinicalinfo.hiv.gov/en/drugs/moxifloxacin-hydrochloride/patient

Moxifloxacin Hydrochloride - Injection solution NIH

Moxifloxacin injection is sterile solution for infusion in a ready-to-use flexible plastic container. Moxifloxacin injection. * 400 mg moxifloxacin ...
clinicalinfo.hiv.gov/en/drugs/moxifloxacin-hydrochloride/injection-solution

Moxifloxacin hydrochloride C21H25ClFN3O4 - PubChem

Moxifloxacin Hydrochloride is the hydrochloride salt of a fluoroquinolone antibacterial antibiotic. Moxifloxacin binds to and inhibits the bacterial ...
pubchem.ncbi.nlm.nih.gov/compound/Moxifloxacin-hydrochloride

PDF NDA 021085 Bayer Response 12 Oct 10

(moxifloxacin hydrochloride) Injection, solution for IV use Initial U.S. Approval: 1999 . To reduce the development of drug-resistant bacteria and ...
www.accessdata.fda.gov/drugsatfda_docs/label/2010/021277s038lbl.pdf

PDF VIGAMOX moxifloxacin hydrochloride ophthalmic solution ...

moxifloxacin. The plasma half-life of moxifloxacin was estimated to be 13 hours. Microbiology: Moxifloxacin is an 8-methoxy fluoroquinolone with a ...
www.accessdata.fda.gov/drugsatfda_docs/label/2004/21598slr002_vigamox_lbl.pdf

Clinical Review Avelox - FDA

Moxifloxacin hydrochloride is a synthetic broad spectrum antimicrobial agent available as tablets for oral administration and as an aqueous solution ...
www.fda.gov/media/101211/download

Tolerability of moxifloxacin in patients with antibiotic ...

Moxifloxacin is a new fluoroquinolone antibacterial agent with a broad spectrum activity. Allergic reactions to moxifloxacin have rarely been ...
pubmed.ncbi.nlm.nih.gov/15777522/

PDF HIGHLIGHTS OF PRESCRIBING INFORMATION AVELOX AVELOX.

AVELOX (moxifloxacin) tablets, for oral use AVELOX (moxifloxacin) injection, for intravenous use Initial U.S. Approval: 1999 . WARNING: SERIOUS ...
www.accessdata.fda.gov/drugsatfda_docs/label/2020/021085s066,021277s062lbl.pdf

Medication Guide Moxifloxacin Injection

4 . moxifloxacin injection is safe and works in people under 18 years of age. Children have a higher chance of getting bone, joint, and tendon ...
www.fda.gov/media/99094/download

DailyMed - MOXIFLOXACIN solution drops

Moxifloxacin ophthalmic solution is a topical fluoroquinolone anti-infective indicated for the treatment of bacterial conjunctivitis caused by ...
dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8877013d-9b49-40f7-a2c4-99bb519e104e

DailyMed - MOXIFLOXACIN OPHTHALMIC SOLUTION- moxifloxacin ...

Moxifloxacin ophthalmic solution 0.5% is a sterile solution for topical ophthalmic use. Moxifloxacin hydrochloride is an 8-methoxy fluoroquinolone ...
dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fc88791b-24da-48a4-85f5-93a8af3d0b51

Drug Approval Package Avelox Moxifloxacin Hydrochloride ...

Avelox (Moxifloxacin Hydrochloride) TabletsCompany: Bayer CorporationApplication No.: 21-085Approval Date: 12/10/1999. Approval Letter (s) (PDF) ...
www.accessdata.fda.gov/drugsatfda_docs/nda/99/21-085_Avelox.cfm

DailyMed - MOXIFLOXACIN- moxifloxacin hydrochloride tablet ...

Moxifloxacin is approximately 3050% bound to serum proteins, independent of drug concentration. The volume of distribution of moxifloxacin ranges ...
dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=78039242-3472-0b54-e053-2a91aa0a2651

Effects of three fluoroquinolones on QT interval in ...

Objective: A clinical trial was conducted in healthy adult volunteers to assess the effect of levofloxacin, moxifloxacin, and ciprofloxacin on the QT ...
pubmed.ncbi.nlm.nih.gov/12709719/

Moxifloxacin-induced QT interval prolongation and torsades ...

Introduction: Moxifloxacin is widely used for the treatment of a number of infectious diseases because of its favorable pharmacological profile and ...
pubmed.ncbi.nlm.nih.gov/30193085/

DailyMed - MOXIFLOXACIN OPHTHALMIC SOLUTION- moxifloxacin ...

Moxifloxacin ophthalmic solution is a topical fluoroquinolone anti-infective indicated for the treatment of bacterial conjunctivitis caused by ...
dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=95773bca-0791-4bfe-955a-4d2fa4561e01